TG Therapeutics Q4 2024 Earnings Preview

by
Contributor since / Followers

1 month ago

TG Therapeutics (NASDAQ:TGTX) is scheduled to announce Q4 earnings results on Monday, March 3rd, before market open.
The consensus EPS Estimate is $0.17 (+288.9% Y/Y) and the consensus Revenue Estimate is $100.67M (+151.7% Y/Y).
Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 2 upward revisions and 1 downward.

Tags: TGTX